Search

Displaying results 8321 - 8330 of 10000 in total
  1. Drug

    LY-2183240

    go.drugbank.com/drugs/DB17035
    Experimental

    LY-2183240 is an inhibitor of endocannabinoid reuptake/breakdown.[A253037]

    Synonyms: 5-(biphenyl-4-ylmethyl)-n,n-dimethyl-1h-tetrazole-1-carboxamide, 1h-tetrazole-1-carboxamide, 5-((1,1'-biphenyl)-4-ylmethyl)-n,n-dimethyl-
  2. Drug

    Tamrintamab pamozirine

    go.drugbank.com/drugs/DB17222
    Investigational

    Tamrintamab pamozirine is an antibody-drug conjugate targeted against DPEP3.

  3. Drug

    UX053

    go.drugbank.com/drugs/DB18558
    Investigational

    UX053 is an mRNA encoding the human glycogen debranching enzyme.

  4. Drug

    TN-301

    go.drugbank.com/drugs/DB32867
    Experimental

    TN-301 is a small-molecule histone deacetylase 6 inhibitor.

  5. Drug

    GA31

    go.drugbank.com/drugs/DB32871
    Experimental

    GA31 is an 31-amino acid TREM-1 inhibitory peptide.

  6. Drug

    Crobenetine

    go.drugbank.com/drugs/DB21095
    Investigational

    Crobenetine is under investigation in clinical trial NCT02273466 (Pharmacokinetics of Oral Desipramine With and Without Concomitant Administration of Crobenetine Infusion in Healthy Male Subjects).

  7. Drug

    Dalzanemdor

    go.drugbank.com/drugs/DB21549
    Investigational

    Dalzanemdor is under investigation in clinical trial NCT05655520 (A Study to Evaluate the Safety and Tolerability of SAGE-718 in Participants With Huntington's Disease).

  8. Drug

    Efimosfermin alfa

    go.drugbank.com/drugs/DB28564
    Investigational

    Efimosfermin Alfa is under investigation in clinical trial NCT07221188 (A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected

  9. Drug

    Freneslerbart

    go.drugbank.com/drugs/DB19080
    Investigational

    Freneslerbart is under investigation in clinical trial NCT04981717 (A Study to Examine the Efficacy and Safety of Anti-fel D 1 Antibodies Injections in Cat-allergic Adolescent and Adult Patients With Allergic

  10. Drug

    Rosabulin

    go.drugbank.com/drugs/DB20161
    Investigational

    Rosabulin is under investigation in clinical trial NCT00276913 (A Phase I Study of STA-5312 in Subjects With Advanced or Metastatic Solid Tumors).